executive team

R. Anthony Williamson, PhD
Co-Founder & CEO

Anthony has over 18 years of experience as a discovery research scientist and entrepreneur, holding leadership positions in academia (The Scripps Research Institute), biotechnology (Prion Solutions, Calmune Corporation) and pharma (Janssen); with a proven ability to evaluate technology, develop strategy and build highly innovative and collaborative international multi-discipline research programs. As Chief Executive Officer, Anthony will define AlphaBiomics' business and technology strategy and coordinate its implementation in an ethical manner, returning value to stakeholders.

Angélique B. van ’t Wout, PhD
Co-Founder & COO

Angélique is an experienced program and project leader, who has worked extensively on the omics of host-pathogen interactions in academia (Universities of Leiden, Amsterdam and Washington) as well as on pre-clinical proof of concept studies for preventive interventions in industry (Janssen). Proven ability to add value along the entire discovery process from conception, fundraising, building and managing teams and collaborations, to execution and reporting. As Chief Operations Officer at AlphaBiomics, Angélique builds the academic and industry partnerships for patient sample collection and data generation.

Marcus Rauch, PhD
Co-Founder & CSO

Marcus is a microbiologist with 18+ years of experience in academia and pharma. He focused his research interest on microbiome sciences while a staff scientist at the University of California, San Francisco. More recently, as a Principal Scientist at Janssen and Head of a microbiome lab, he led a cross-disciplinary team and successfully built and managed internal & external collaborations. Marcus is an author on multiple peer-reviewed publications as well as the recipient of several awards/fellowships. As Chief Scientific Officer at AlphaBiomics, he oversees research operations, defines scientific standards, and sets scientific priorities